Details of Disease

Disease Name

Neurodevelopmental disorder

Definition

A behavioral and cognitive disorder with onset during the developmental period that involves impaired or aberrant development of intellectual, motor, or social functions.

Disease Hierarchy

DISCFBRD: Neurological disorder

DIS372XH: Neurodevelopmental disorder

Disease Identifiers

MONDO ID

MONDO_0700092

MESH ID

D065886

UMLS CUI

C1535926

MedGen ID

453059

SNOMED CT ID

700364009

General Information of Disease (ID: DIS372XH)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

This Disease Is Related to 79 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ADGRL3	TTQST3U	Limited	Biomarker	[1]
CACNA1D	TT7RGTM	Limited	Genetic Variation	[2]
EIF4EBP2	TTNBTCW	Limited	Altered Expression	[3]
GABRA1	TT1MPAY	Limited	Genetic Variation	[4]
GABRG2	TT06RH5	Limited	Genetic Variation	[4]
GRIN2B	TTN9D8E	Limited	Genetic Variation	[4]
GRM2	TTXJ47W	Limited	Biomarker	[5]
KCNQ3	TTIVDM3	Limited	Genetic Variation	[6]
PPP2CA	TTHTKNY	Limited	Genetic Variation	[7]
PPP3CA	TTA4LDE	Limited	Biomarker	[8]
RAC3	TT9BQ50	Limited	Genetic Variation	[9]
SCN3A	TTAXZ0K	Limited	Genetic Variation	[10]
UBE3A	TTUZX6V	Limited	Biomarker	[11]
BRSK2	TTHZN4X	moderate	Genetic Variation	[12]
CACNA1E	TTYRP0M	moderate	Biomarker	[13]
CHRNA7	TTLA931	moderate	Biomarker	[14]
DAGLA	TTRQ6UD	moderate	Biomarker	[15]
ENPEP	TT9PBIL	moderate	Biomarker	[16]
FBXO11	TT6G10V	moderate	Biomarker	[17]
GABRG3	TTEX6LM	moderate	Biomarker	[18]
OXTR	TTSCIUP	moderate	Genetic Variation	[19]
PAK1	TTFN95D	moderate	Biomarker	[20]
PDE10A	TTJW4LU	moderate	Genetic Variation	[21]
PNKP	TTHR3IE	moderate	Genetic Variation	[22]
RORB	TTGB2LZ	moderate	Genetic Variation	[23]
SERPINH1	TTPSWQG	moderate	Biomarker	[24]
SLC12A5	TTH6UZY	moderate	Altered Expression	[25]
TPH2	TT3KLDP	moderate	Biomarker	[26]
BCL11A	TTR61MW	Strong	Biomarker	[27]
CACNA1A	TTX4QDJ	Strong	Biomarker	[28]
CACNA1C	TTZIFHC	Strong	Genetic Variation	[29]
DHPS	TTBO2A9	Strong	Genetic Variation	[30]
DLG4	TT9PB26	Strong	Biomarker	[31]
DNM1	TTE3JW9	Strong	Biomarker	[13]
DYRK1A	TTSBVFO	Strong	Genetic Variation	[32]
EIF5A	TTIVCNR	Strong	Genetic Variation	[30]
FOXP1	TT0MUCI	Strong	Biomarker	[33]
GABRB2	TTZA1NY	Strong	Genetic Variation	[13]
GNAO1	TTAXD8Z	Strong	Biomarker	[13]
GREM1	TTOUZN5	Strong	Biomarker	[34]
GRIA2	TTWM461	Strong	Genetic Variation	[35]
GRIA4	TTPJR0G	Strong	Genetic Variation	[36]
GRIK2	TT0K5RG	Strong	Genetic Variation	[37]
GRIN2A	TTKJEMQ	Strong	Biomarker	[38]
GRM5	TTHS256	Strong	Biomarker	[39]
GRM7	TT0I76D	Strong	Biomarker	[40]
HTR7	TTO9X1H	Strong	Biomarker	[41]
HTT	TTIWZ0O	Strong	Genetic Variation	[42]
KAT6A	TT6O1J0	Strong	Genetic Variation	[43]
KCNA2	TTVFB0O	Strong	Biomarker	[44]
KCNB1	TT5OEKU	Strong	Biomarker	[45]
KCNH1	TT9XKUC	Strong	Biomarker	[13]
KCNQ2	TTPXI3S	Strong	Genetic Variation	[6]
KDM5B	TTCLI75	Strong	Altered Expression	[46]
KDM5C	TT94UCF	Strong	Altered Expression	[47]
L1CAM	TTC9D3K	Strong	Genetic Variation	[48]
PHF8	TT81PFE	Strong	Altered Expression	[47]
PPM1D	TTENJAB	Strong	Biomarker	[33]
PTEN	TTXJ3W7	Strong	Genetic Variation	[49]
SCN1A	TTANOZH	Strong	Genetic Variation	[50]
SCN2A	TTLJTUF	Strong	Genetic Variation	[51]
SCN8A	TT54ERL	Strong	Biomarker	[13]
SLC6A1	TTPRKM0	Strong	Biomarker	[13]
SNAP25	TTYQWA0	Strong	Biomarker	[13]
SOX5	TTXHSZK	Strong	Genetic Variation	[52]
TAOK1	TTQY9DH	Strong	Biomarker	[53]
TRIP12	TTG2CRH	Strong	Biomarker	[33]
USP7	TTXU3EQ	Strong	Genetic Variation	[54]
ADCY5	TTN64VU	Definitive	Biomarker	[33]
CACNA2D3	TTN7T29	Definitive	Biomarker	[33]
CUL3	TTPCU0Q	Definitive	Biomarker	[33]
ITPR1	TT5HWAT	Definitive	Biomarker	[33]
KMT2A	TT1GNDM	Definitive	Biomarker	[33]
KMT5B	TTJGV7F	Definitive	Biomarker	[33]
PAX5	TTA4REJ	Definitive	Biomarker	[33]
PTK7	TTXH2ZN	Definitive	Biomarker	[33]
PTPN11	TT7WUAV	Definitive	Biomarker	[33]
SETD2	TTPC3H4	Definitive	Biomarker	[33]
TBL1XR1	TTYXT16	Definitive	Biomarker	[33]
------------------------------------------------------------------------------------


⏷ Show the Full List of 79 DTT(s)

This Disease Is Related to 2 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC1A4	DTC54PX	Strong	Genetic Variation	[55]
SLC35A2	DT0567K	Strong	Genetic Variation	[42]
------------------------------------------------------------------------------------

This Disease Is Related to 4 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
ASNS	DEXISVQ	Limited	Biomarker	[56]
DIO3	DET89OV	Limited	Biomarker	[57]
VARS1	DEUPF5K	Limited	Biomarker	[58]
WARS2	DEPTKBQ	Limited	Genetic Variation	[59]
------------------------------------------------------------------------------------

This Disease Is Related to 259 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
AGMO	OTGMAHAT	Limited	Genetic Variation	[60]
ALDH1L1	OT15HOJX	Limited	Altered Expression	[61]
AMBRA1	OTY0YGT9	Limited	Altered Expression	[62]
AP1S2	OTZHJFYI	Limited	Genetic Variation	[63]
CALB2	OTSNMCG9	Limited	Biomarker	[64]
CCDC88C	OTIU02BS	Limited	Biomarker	[65]
CHD4	OTBDEHDP	Limited	Biomarker	[66]
CNOT3	OT4D5Z9L	Limited	Genetic Variation	[67]
COL9A3	OTCUJOEK	Limited	Biomarker	[68]
CPQ	OTTNZNLD	Limited	Biomarker	[69]
CUX2	OTDJTQAJ	Limited	Biomarker	[70]
DARS1	OT0WGC2T	Limited	Biomarker	[71]
DARS2	OTVPFTBG	Limited	Biomarker	[71]
DGCR2	OTEGL17Z	Limited	Biomarker	[68]
DLGAP4	OTNELLIN	Limited	Biomarker	[72]
DMXL2	OTB4JWN3	Limited	Biomarker	[73]
DOCK3	OTF3YS2W	Limited	Genetic Variation	[74]
DPH1	OT0QU3JY	Limited	Genetic Variation	[75]
DPYSL5	OT6F9T6F	Limited	Altered Expression	[61]
EEF1B2	OTW64NPU	Limited	Biomarker	[58]
EEF1D	OTM5ZD8Y	Limited	Biomarker	[58]
EIF4A1	OTMTBX6N	Limited	Biomarker	[76]
EXOSC3	OTNCF906	Limited	Genetic Variation	[77]
FBLIM1	OTFHXMON	Limited	Biomarker	[78]
FEM1B	OTFE2ELA	Limited	Biomarker	[79]
FMN2	OTUY7BSV	Limited	Biomarker	[80]
GNAI2	OTTLGRGH	Limited	Biomarker	[79]
GNB5	OT3ZSAXH	Limited	Genetic Variation	[81]
GNPAT	OTF6LWPO	Limited	Biomarker	[82]
GTPBP2	OTOJ1KUA	Limited	Biomarker	[83]
GUK1	OTLI0HRU	Limited	Biomarker	[84]
H2AZ1	OT3KJJNQ	Limited	Genetic Variation	[85]
IMMP2L	OT9WGAFD	Limited	Biomarker	[86]
INTS1	OT7TY1M1	Limited	Genetic Variation	[87]
KANK1	OT2E7A6W	Limited	Genetic Variation	[88]
KCTD13	OTSKZ1KM	Limited	Biomarker	[89]
KIF21A	OT511XD9	Limited	Biomarker	[90]
LHX2	OTK61NP8	Limited	Biomarker	[70]
LMX1B	OTM8145D	Limited	Biomarker	[91]
MACROD2	OTNQCHC6	Limited	Biomarker	[92]
MEF2A	OTV2SF6E	Limited	Biomarker	[93]
MEF2C	OTZGF1Y5	Limited	Altered Expression	[94]
MEPCE	OTRBQEYP	Limited	Genetic Variation	[95]
NAA15	OT53SIZG	Limited	Biomarker	[96]
NAXE	OTRZPISQ	Limited	Biomarker	[97]
NFASC	OTBDUXZT	Limited	Genetic Variation	[98]
NFIC	OTLMCUIB	Limited	Biomarker	[99]
NLGN3	OTKDEC1Q	Limited	Biomarker	[100]
NPAS3	OT8D1ILB	Limited	Altered Expression	[101]
PCDH19	OTSOW3MV	Limited	Genetic Variation	[4]
PHF6	OT8DXI40	Limited	Biomarker	[102]
POGZ	OT4CYWC1	Limited	Biomarker	[103]
PRR12	OTY2ILFT	Limited	Biomarker	[104]
PRUNE1	OTQ3UHWQ	Limited	Genetic Variation	[105]
PSD	OTUZIXUZ	Limited	Biomarker	[106]
PTPN4	OT6SXU5Y	Limited	Biomarker	[107]
RARS1	OTHPZ6JN	Limited	Biomarker	[71]
RARS2	OT3WLAD8	Limited	Biomarker	[71]
SCAMP5	OT9MXA2J	Limited	Biomarker	[108]
SMARCA5	OT5GR4Z2	Limited	Biomarker	[109]
SOX3	OT1CRCOB	Limited	Genetic Variation	[110]
SRPX2	OT6A63TX	Limited	Biomarker	[111]
ST3GAL3	OTOORKUE	Limited	Genetic Variation	[112]
TAF1	OTDYS5G4	Limited	Genetic Variation	[113]
TANC1	OTF6TZ8E	Limited	Biomarker	[114]
TAOK2	OTNUMOZ1	Limited	Biomarker	[115]
TBC1D24	OTKZUSMD	Limited	Biomarker	[116]
TLK1	OTICTXI8	Limited	Altered Expression	[117]
TMEM94	OTT4ZSUA	Limited	Biomarker	[118]
TNPO3	OTOT3HH0	Limited	Biomarker	[119]
TOP3B	OTNFEUOO	Limited	Biomarker	[120]
TSPYL2	OTGGW2EF	Limited	Genetic Variation	[121]
AFF3	OTR0705Z	moderate	Biomarker	[122]
AP4M1	OT2BG2Z3	moderate	Genetic Variation	[123]
APH1B	OTQHPTGC	moderate	Biomarker	[124]
ARHGEF9	OTB1FLIW	moderate	Genetic Variation	[125]
ASTN2	OTF0W2FJ	moderate	Altered Expression	[126]
ATL1	OTR2788Y	moderate	Genetic Variation	[127]
BRINP1	OTEUVSCP	moderate	Genetic Variation	[128]
CAPS2	OT45M743	moderate	Biomarker	[129]
CC2D1A	OTVPU04K	moderate	Genetic Variation	[130]
CDYL	OTCUK5KZ	moderate	Biomarker	[131]
CHD8	OTS7A6AF	moderate	Genetic Variation	[132]
CNTNAP1	OT5Y03EU	moderate	Genetic Variation	[133]
CPA6	OT43RD23	moderate	Biomarker	[134]
DHX30	OT7W9CEZ	moderate	Biomarker	[135]
DIAPH1	OTZBYPLH	moderate	Genetic Variation	[136]
EIF3A	OTFABY9G	moderate	Biomarker	[137]
ELP4	OTP5GZ9V	moderate	Genetic Variation	[138]
EN2	OT7EZCM2	moderate	Genetic Variation	[139]
EPG5	OT3P5HQD	moderate	Biomarker	[140]
FAM124B	OTL2A8O8	moderate	Biomarker	[141]
FZD9	OTTZ9MKK	moderate	Genetic Variation	[142]
GDI1	OTYM3928	moderate	Biomarker	[143]
GIT1	OTHO92S5	moderate	Biomarker	[144]
GTDC1	OT8OBXKK	moderate	Biomarker	[145]
GTF2IRD1	OTEG9KU1	moderate	Biomarker	[146]
HCFC1	OT0UCK62	moderate	Biomarker	[147]
HMGN1	OTSMGH99	moderate	Biomarker	[148]
KIF5C	OT35570Y	moderate	Genetic Variation	[149]
KLF16	OTTPV4NB	moderate	Genetic Variation	[150]
LAMB1	OT6J9LJR	moderate	Altered Expression	[151]
LRRC4C	OT5QI5EP	moderate	Biomarker	[152]
LRRTM1	OTKI3IU9	moderate	Biomarker	[153]
MICU2	OTZY0PM2	moderate	Genetic Variation	[154]
MSANTD2	OTDNNUJZ	moderate	Genetic Variation	[150]
NCAM2	OT8LBJN8	moderate	Genetic Variation	[155]
NDE1	OT2N8Q17	moderate	Biomarker	[156]
NDEL1	OTAGFML5	moderate	Biomarker	[156]
NDP	OTGDJ4US	moderate	Genetic Variation	[157]
NEDD4L	OT1B19RU	moderate	Genetic Variation	[158]
NLGN2	OTHDYL3H	moderate	Genetic Variation	[125]
NLGN4X	OTDJGBK8	moderate	Genetic Variation	[125]
NRXN2	OTB04QSU	moderate	Genetic Variation	[125]
NRXN3	OTJ0I7HJ	moderate	Genetic Variation	[125]
NTNG1	OTF48IID	moderate	Biomarker	[159]
NUDT2	OTMHM1DH	moderate	Genetic Variation	[160]
NUFIP2	OTZBZ224	moderate	Genetic Variation	[161]
PHF21A	OTU3FFG4	moderate	Genetic Variation	[162]
PHOX2B	OT3SFR2O	moderate	Genetic Variation	[163]
PIK3C3	OTLUM9L7	moderate	Biomarker	[164]
PPP1R9A	OTJL2TOC	moderate	Biomarker	[144]
PRKN	OTJBN41W	moderate	Genetic Variation	[165]
PTCHD1	OTFDLU5S	moderate	Biomarker	[166]
RAB40AL	OTZWO8A5	moderate	Genetic Variation	[167]
RAI1	OTKLQU00	moderate	Genetic Variation	[168]
RBFOX3	OTL0F3D6	moderate	Biomarker	[169]
RNF2	OTFPLOIN	moderate	Altered Expression	[170]
SECISBP2	OTBXUURJ	moderate	Biomarker	[171]
SEPSECS	OTP0FHOV	moderate	Genetic Variation	[171]
SETDB1	OTWVUA1B	moderate	Genetic Variation	[172]
SH2B1	OTJZO2CI	moderate	Genetic Variation	[173]
SLU7	OTZUUICN	moderate	Biomarker	[174]
TANC2	OTDXY7PX	moderate	Biomarker	[175]
ACTL6B	OTO7EJIS	Strong	Genetic Variation	[176]
AHDC1	OTQ1VL2W	Strong	Biomarker	[177]
ALG13	OTOH9PMY	Strong	Biomarker	[13]
ANK3	OTJ3IRBP	Strong	Genetic Variation	[178]
ANKRD11	OTV0V70M	Strong	Biomarker	[13]
ANKS1B	OT26DGM9	Strong	Biomarker	[179]
ARHGEF2	OTBQTFRT	Strong	Biomarker	[180]
ARSD	OTAHW9M8	Strong	Biomarker	[181]
ARX	OTBGYH25	Strong	Genetic Variation	[47]
ASH1L	OTUT5NLJ	Strong	Genetic Variation	[182]
ASTN1	OT23FQIB	Strong	Altered Expression	[183]
ASXL3	OTNDJWEZ	Strong	Biomarker	[13]
ATP1A3	OTM8EG6H	Strong	Biomarker	[184]
AUTS2	OTAEXHSC	Strong	Biomarker	[185]
BANF1	OTP7Z38L	Strong	Genetic Variation	[186]
BCL11B	OT8KKCVJ	Strong	Genetic Variation	[187]
BPTF	OTD1RZAD	Strong	Biomarker	[188]
CASK	OT8EF7ZF	Strong	Biomarker	[84]
CBLL2	OTB4AD3V	Strong	Genetic Variation	[165]
CCNK	OTZ7JBPK	Strong	Genetic Variation	[189]
CERT1	OTNUCNHX	Strong	Biomarker	[13]
CHD2	OTRKL6YC	Strong	Genetic Variation	[190]
CNTN4	OTULXVE0	Strong	Biomarker	[191]
CNTN5	OTWU5FLZ	Strong	Genetic Variation	[192]
CNTN6	OTXVGVOR	Strong	Biomarker	[193]
CSNK2B	OT2WW7R1	Strong	Genetic Variation	[194]
CTCF	OT8ZB70U	Strong	Genetic Variation	[195]
CYFIP2	OTCAY35T	Strong	Biomarker	[196]
DDX3X	OTDO4TRX	Strong	Biomarker	[135]
DDX6	OTKWXVDY	Strong	Biomarker	[135]
DEAF1	OTCLX3ZW	Strong	Genetic Variation	[197]
DISC1	OT43AW4H	Strong	Genetic Variation	[198]
DLG2	OTQ3BD8U	Strong	Biomarker	[31]
DOCK8	OTNQLL21	Strong	Genetic Variation	[199]
DPP6	OTWW3H0K	Strong	Biomarker	[200]
DTNBP1	OT9UQT2S	Strong	Biomarker	[201]
EEF1A2	OT9Z23K5	Strong	Biomarker	[202]
EIF2B2	OTQQMHM1	Strong	Genetic Variation	[42]
EIF4G1	OT2CF1E6	Strong	Genetic Variation	[42]
FMR1	OTWEV0T5	Strong	Genetic Variation	[203]
FOXG1	OTAW57J4	Strong	Biomarker	[204]
FOXP2	OTVX6A59	Strong	Biomarker	[205]
FZR1	OT0WGWZS	Strong	Genetic Variation	[206]
GABBR2	OT67RIFY	Strong	Genetic Variation	[42]
GABRB3	OT80C3D4	Strong	Biomarker	[13]
GATAD2B	OTJL128N	Strong	Biomarker	[207]
GNB1	OTLL7L74	Strong	Genetic Variation	[208]
GPHN	OTAKK1SV	Strong	Genetic Variation	[209]
HACE1	OTEZULKD	Strong	Genetic Variation	[210]
HECW2	OTP2IN12	Strong	Genetic Variation	[211]
HERC2	OTNQYKOB	Strong	Genetic Variation	[212]
HNRNPH2	OTMGP4J7	Strong	Genetic Variation	[213]
HNRNPU	OTLQN1E2	Strong	Biomarker	[13]
HUWE1	OTFH6BJS	Strong	Genetic Variation	[43]
IQSEC2	OTYFRM4Q	Strong	Biomarker	[13]
KIRREL3	OTW7PENS	Strong	Biomarker	[214]
KMT2E	OTYOLNOG	Strong	Genetic Variation	[215]
MAB21L1	OT8FJMU8	Strong	Genetic Variation	[216]
MAGEL2	OTXEL4R7	Strong	Genetic Variation	[217]
MBD5	OTFHT4MO	Strong	Genetic Variation	[80]
MCPH1	OTYT3TT5	Strong	Genetic Variation	[218]
MED13	OTP5LEJE	Strong	Genetic Variation	[219]
MUL1	OT2JC9YR	Strong	Genetic Variation	[165]
MYT1L	OTV45MAS	Strong	Biomarker	[33]
NEXMIF	OT576F40	Strong	Biomarker	[220]
NPAS4	OTA3HH6W	Strong	Altered Expression	[221]
NRG3	OTIFZ5CT	Strong	Biomarker	[222]
NSUN2	OTZCNM33	Strong	Biomarker	[223]
NTNG2	OTTY88DL	Strong	Genetic Variation	[224]
PHACTR1	OTAMPX9V	Strong	Genetic Variation	[225]
PIK3AP1	OTMW1B47	Strong	Biomarker	[226]
POU3F3	OT6BBXPD	Strong	Genetic Variation	[227]
PRPF8	OTU39JZI	Strong	Autosomal dominant	[228]
PSMD12	OTWICA51	Strong	Genetic Variation	[229]
PURA	OT975ELW	Strong	Biomarker	[13]
PVALB	OTZW1WVQ	Strong	Biomarker	[221]
RAB11A	OTC4FW0J	Strong	Genetic Variation	[230]
RBFOX1	OTFPKEL7	Strong	Genetic Variation	[231]
RELN	OTLKMW1O	Strong	Biomarker	[232]
RHOBTB2	OT2DATFX	Strong	Genetic Variation	[42]
RPL10	OTBHOZGC	Strong	Genetic Variation	[233]
SATB2	OT2W80XC	Strong	Genetic Variation	[234]
SETD1A	OTVVWRIC	Strong	Genetic Variation	[235]
SETD5	OTRPAVEO	Strong	Genetic Variation	[236]
SHANK2	OTSQTPFQ	Strong	Genetic Variation	[237]
SHROOM4	OT33GO6E	Strong	Genetic Variation	[42]
SLC2A4RG	OTW3LX8D	Strong	Biomarker	[180]
SMARCA1	OT0Y6PTU	Strong	Genetic Variation	[238]
SMARCA2	OTSGJ8SV	Strong	Genetic Variation	[239]
SMARCC2	OTC5SNMZ	Strong	Genetic Variation	[240]
SMC1A	OT9ZMRK9	Strong	Biomarker	[13]
SNRPN	OTQB1ID1	Strong	Biomarker	[21]
STRADA	OTG1Z6TY	Strong	Genetic Variation	[241]
STXBP1	OTRYA8C3	Strong	Biomarker	[242]
SYNGAP1	OT41HVYQ	Strong	Genetic Variation	[243]
TBR1	OT14JQT8	Strong	Genetic Variation	[244]
TCF4	OTB9ASTK	Strong	Biomarker	[245]
TFE3	OTM99ZWH	Strong	Biomarker	[246]
TLK2	OTZ09CG8	Strong	Genetic Variation	[117]
TRAK1	OTMQVYNP	Strong	Biomarker	[247]
TRIM32	OTJOV0PG	Strong	Biomarker	[248]
TRIO	OT71X1AK	Strong	Biomarker	[249]
ADNP	OTEGICWR	Definitive	Biomarker	[33]
ANK2	OTWB4R1Y	Definitive	Biomarker	[33]
CDC42BPB	OTO6NT7Q	Definitive	Biomarker	[33]
DLGAP1	OTF2PUUI	Definitive	Biomarker	[33]
DSCAM	OTL7PRMK	Definitive	Biomarker	[33]
GIGYF2	OTFNVEJ4	Definitive	Biomarker	[33]
HIVEP3	OTM3QT3L	Definitive	Biomarker	[33]
ILF2	OTWWVM9X	Definitive	Biomarker	[33]
KATNAL2	OTL33OIT	Definitive	Biomarker	[33]
KMT2C	OTC59BCO	Definitive	Biomarker	[33]
MED13L	OTSP1W0F	Definitive	Biomarker	[33]
NCKAP1	OTEZQXXJ	Definitive	Biomarker	[33]
PARD3B	OTGZ43YI	Definitive	Biomarker	[33]
PHF2	OTJCIQR2	Definitive	Biomarker	[33]
PLXNB1	OTCA7JIT	Definitive	Biomarker	[33]
PPP2R5D	OT43TTX0	Definitive	Biomarker	[33]
RIMS1	OT10T7CK	Definitive	Biomarker	[33]
SETBP1	OTKGCOSR	Definitive	Biomarker	[33]
SMC3	OTWGFRHD	Definitive	Biomarker	[33]
SPAST	OTIF3AJI	Definitive	Biomarker	[33]
SRCAP	OT82P6CN	Definitive	Biomarker	[33]
SRGAP3	OT9ZS72C	Definitive	Biomarker	[33]
TNRC6B	OTGVT0SH	Definitive	Biomarker	[33]
------------------------------------------------------------------------------------


⏷ Show the Full List of 259 DOT(s)

References

1	ADGRL3 rs6551665 as a Common Vulnerability Factor Underlying Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.Neuromolecular Med. 2019 Mar;21(1):60-67. doi: 10.1007/s12017-019-08525-x. Epub 2019 Jan 16.
2	Gating defects of disease-causing de novo mutations in Ca(v)1.3 Ca(2+) channels.Channels (Austin). 2018;12(1):388-402. doi: 10.1080/19336950.2018.1546518.
3	Raptor-Mediated Proteasomal Degradation of Deamidated 4E-BP2 Regulates Postnatal Neuronal Translation and NF-B Activity.Cell Rep. 2019 Dec 10;29(11):3620-3635.e7. doi: 10.1016/j.celrep.2019.11.023.
4	High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders.Genet Med. 2018 Apr;20(4):403-410. doi: 10.1038/gim.2017.114. Epub 2017 Aug 24.
5	Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors.Front Mol Neurosci. 2018 Nov 30;11:423. doi: 10.3389/fnmol.2018.00423. eCollection 2018.
6	Heterozygous loss of epilepsy gene KCNQ2 alters social, repetitive and exploratory behaviors.Genes Brain Behav. 2020 Jan;19(1):e12599. doi: 10.1111/gbb.12599. Epub 2019 Jul 31.
7	De Novo Mutations Affecting the Catalytic C Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.Am J Hum Genet. 2019 Jan 3;104(1):139-156. doi: 10.1016/j.ajhg.2018.12.002. Epub 2018 Dec 27.
8	Novel calcineurin A (PPP3CA) variant associated with epilepsy, constitutive enzyme activation and downregulation of protein expression.Eur J Hum Genet. 2019 Jan;27(1):61-69. doi: 10.1038/s41431-018-0254-8. Epub 2018 Sep 25.
9	A de novo variant in RAC3 causes severe global developmental delay and a middle interhemispheric variant of holoprosencephaly.J Hum Genet. 2019 Nov;64(11):1127-1132. doi: 10.1038/s10038-019-0656-7. Epub 2019 Aug 16.
10	Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants: two new cases and review of the literature.Brain Dev. 2020 Feb;42(2):211-216. doi: 10.1016/j.braindev.2019.09.004. Epub 2019 Oct 31.
11	Analysis of ubiquitin recognition by the HECT ligase E6AP provides insight into its linkage specificity.J Biol Chem. 2019 Apr 12;294(15):6113-6129. doi: 10.1074/jbc.RA118.007014. Epub 2019 Feb 8.
12	Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder. Am J Hum Genet. 2019 Apr 4;104(4):701-708. doi: 10.1016/j.ajhg.2019.02.002. Epub 2019 Mar 14.
13	De novo variants in neurodevelopmental disorders with epilepsy.Nat Genet. 2018 Jul;50(7):1048-1053. doi: 10.1038/s41588-018-0143-7. Epub 2018 Jun 25.
14	15q13.3 duplication in two patients with childhood-onset schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2016 Sep;171(6):777-83. doi: 10.1002/ajmg.b.32439. Epub 2016 Mar 10.
15	Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans.PLoS One. 2017 Nov 16;12(11):e0187926. doi: 10.1371/journal.pone.0187926. eCollection 2017.
16	How Stuttering Develops: The Multifactorial Dynamic Pathways Theory.J Speech Lang Hear Res. 2017 Sep 18;60(9):2483-2505. doi: 10.1044/2017_JSLHR-S-16-0343.
17	De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder.Am J Hum Genet. 2018 Aug 2;103(2):305-316. doi: 10.1016/j.ajhg.2018.07.003. Epub 2018 Jul 26.
18	No evidence for significant association between GABA receptor genes in chromosome 15q11-q13 and autism in a Japanese population.J Hum Genet. 2007;52(12):985-989. doi: 10.1007/s10038-007-0207-5. Epub 2007 Oct 24.
19	Oxytocin Receptor Polymorphisms are Differentially Associated with Social Abilities across Neurodevelopmental Disorders.Sci Rep. 2017 Sep 14;7(1):11618. doi: 10.1038/s41598-017-10821-0.
20	Activating Mutations in PAK1, Encoding p21-Activated Kinase 1, Cause a Neurodevelopmental Disorder. Am J Hum Genet. 2018 Oct 4;103(4):579-591. doi: 10.1016/j.ajhg.2018.09.005.
21	Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.Cell. 2012 Apr 27;149(3):525-37. doi: 10.1016/j.cell.2012.03.028. Epub 2012 Apr 19.
22	Microcephalic primordial dwarfism in an Emirati patient with PNKP mutation.Am J Med Genet A. 2016 Aug;170(8):2127-32. doi: 10.1002/ajmg.a.37766. Epub 2016 May 27.
23	Loss of function of the retinoid-related nuclear receptor (RORB) gene and epilepsy.Eur J Hum Genet. 2016 Dec;24(12):1761-1770. doi: 10.1038/ejhg.2016.80. Epub 2016 Jun 29.
24	Effect of Tetrabromobisphenol A on expression of biomarkers for inflammation and neurodevelopment by the placenta.Placenta. 2018 Aug;68:33-39. doi: 10.1016/j.placenta.2018.06.306. Epub 2018 Jun 20.
25	Mild Intrauterine Hypoperfusion Leads to Lumbar and Cortical Hyperexcitability, Spasticity, and Muscle Dysfunctions in Rats: Implications for Prematurity.Front Neurol. 2018 Jun 15;9:423. doi: 10.3389/fneur.2018.00423. eCollection 2018.
26	Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour.Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2426-43. doi: 10.1098/rstb.2012.0039.
27	BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription. Am J Hum Genet. 2016 Aug 4;99(2):253-74. doi: 10.1016/j.ajhg.2016.05.030. Epub 2016 Jul 21.
28	Cognitive impairment in children with CACNA1A mutations.Dev Med Child Neurol. 2020 Mar;62(3):330-337. doi: 10.1111/dmcn.14261. Epub 2019 May 21.
29	An autism-causing calcium channel variant functions with selective autophagy to alter axon targeting and behavior.PLoS Genet. 2019 Dec 5;15(12):e1008488. doi: 10.1371/journal.pgen.1008488. eCollection 2019 Dec.
30	Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder. Am J Hum Genet. 2019 Feb 7;104(2):287-298. doi: 10.1016/j.ajhg.2018.12.017. Epub 2019 Jan 17.
31	An opposing function of paralogs in balancing developmental synapse maturation.PLoS Biol. 2018 Dec 26;16(12):e2006838. doi: 10.1371/journal.pbio.2006838. eCollection 2018 Dec.
32	DYRK1A-haploinsufficiency in mice causes autistic-like features and febrile seizures.Neurobiol Dis. 2018 Feb;110:180-191. doi: 10.1016/j.nbd.2017.12.003. Epub 2017 Dec 6.
33	Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Nat Genet. 2017 Apr;49(4):515-526. doi: 10.1038/ng.3792. Epub 2017 Feb 13.
34	Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.Hum Mol Genet. 2017 Oct 15;26(20):3995-4010. doi: 10.1093/hmg/ddx289.
35	AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders. Nat Commun. 2019 Jul 12;10(1):3094. doi: 10.1038/s41467-019-10910-w.
36	De Novo Variants in GRIA4 Lead to Intellectual Disability with or without Seizures and Gait Abnormalities. Am J Hum Genet. 2017 Dec 7;101(6):1013-1020. doi: 10.1016/j.ajhg.2017.11.004.
37	Kainate Receptors Inhibit Glutamate Release Via Mobilization of Endocannabinoids in Striatal Direct Pathway Spiny Projection Neurons.J Neurosci. 2018 Apr 18;38(16):3901-3910. doi: 10.1523/JNEUROSCI.1788-17.2018. Epub 2018 Mar 14.
38	GRIN2A-related disorders: genotype and functional consequence predict phenotype.Brain. 2019 Jan 1;142(1):80-92. doi: 10.1093/brain/awy304.
39	mGlu5-mediated signalling in developing astrocyte and the pathogenesis of autism spectrum disorders.Curr Opin Neurobiol. 2018 Feb;48:139-145. doi: 10.1016/j.conb.2017.12.014. Epub 2018 Jan 6.
40	Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders.Front Mol Neurosci. 2018 Oct 23;11:387. doi: 10.3389/fnmol.2018.00387. eCollection 2018.
41	Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome.Neuropharmacology. 2017 Jul 15;121:79-88. doi: 10.1016/j.neuropharm.2017.04.024. Epub 2017 Apr 15.
42	Identification of novel genetic causes of Rett syndrome-like phenotypes. J Med Genet. 2016 Mar;53(3):190-9. doi: 10.1136/jmedgenet-2015-103568. Epub 2016 Jan 6.
43	Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability.Am J Med Genet A. 2017 Jan;173(1):62-71. doi: 10.1002/ajmg.a.37969. Epub 2016 Sep 12.
44	De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat Genet. 2015 Apr;47(4):393-399. doi: 10.1038/ng.3239. Epub 2015 Mar 9.
45	Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature.Hum Mutat. 2020 Jan;41(1):69-80. doi: 10.1002/humu.23915. Epub 2019 Oct 4.
46	A novel mosaic 1q32.1 microduplication identified through Chromosome Microarray Analysis: narrowing the smallest critical region including KDM5B gene found associated with neurodevelopmetal disorders.Eur J Med Genet. 2019 Sep;62(9):103558. doi: 10.1016/j.ejmg.2018.10.010. Epub 2018 Oct 25.
47	Histone demethylase KDM5C is a SAHA-sensitive central hub at the crossroads of transcriptional axes involved in multiple neurodevelopmental disorders.Hum Mol Genet. 2019 Dec 15;28(24):4089-4102. doi: 10.1093/hmg/ddz254.
48	L1 syndrome diagnosis complemented with functional analysis of L1CAM variants located to the two N-terminal Ig-like domains.Clin Genet. 2017 Jan;91(1):115-120. doi: 10.1111/cge.12763. Epub 2016 Mar 15.
49	PTEN-opathies: from biological insights to evidence-based precision medicine.J Clin Invest. 2019 Feb 1;129(2):452-464. doi: 10.1172/JCI121277. Epub 2019 Jan 7.
50	Genetic and phenotypic characteristics of SCN1A-related epilepsy in Chinese children.Neuroreport. 2019 Jun 12;30(9):671-680. doi: 10.1097/WNR.0000000000001259.
51	Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum.Psychiatr Genet. 2019 Jun;29(3):91-94. doi: 10.1097/YPG.0000000000000219.
52	Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency.Genet Med. 2020 Mar;22(3):524-537. doi: 10.1038/s41436-019-0657-0. Epub 2019 Oct 3.
53	De Novo Variants in TAOK1 Cause Neurodevelopmental Disorders. Am J Hum Genet. 2019 Jul 3;105(1):213-220. doi: 10.1016/j.ajhg.2019.05.005. Epub 2019 Jun 20.
54	Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.Genet Med. 2019 Aug;21(8):1797-1807. doi: 10.1038/s41436-019-0433-1. Epub 2019 Jan 25.
55	A novel SLC1A4 homozygous mutation causing congenital microcephaly, epileptic encephalopathy and spastic tetraparesis: a video-EEG and tractography - case study.J Neurogenet. 2018 Dec;32(4):316-321. doi: 10.1080/01677063.2018.1476510. Epub 2018 Jul 10.
56	Generation of four induced pluripotent stem cell lines, GZWWTi001-A, GZWTZi001-A, GZWXYi001-A, and GZWXDi001-A, derived from peripheral blood mononuclear cells from a family with asparagine synthetase deficiency.Stem Cell Res. 2019 Dec;41:101583. doi: 10.1016/j.scr.2019.101583. Epub 2019 Oct 25.
57	Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.Genes Brain Behav. 2018 Jan;17(1):23-35. doi: 10.1111/gbb.12400. Epub 2017 Aug 4.
58	The role of translation elongation factor eEF1 subunits in neurodevelopmental disorders.Hum Mutat. 2019 Feb;40(2):131-141. doi: 10.1002/humu.23677. Epub 2018 Nov 23.
59	Expanding the Phenotype: Neurodevelopmental Disorder, Mitochondrial, With Abnormal Movements and Lactic Acidosis, With or Without Seizures (NEMMLAS) due to WARS2 Biallelic Variants, Encoding Mitochondrial Tryptophanyl-tRNA Synthase.J Child Neurol. 2019 Oct;34(12):778-781. doi: 10.1177/0883073819854604. Epub 2019 Jul 8.
60	Biallelic variants in AGMO with diminished enzyme activity are associated with a neurodevelopmental disorder.Hum Genet. 2019 Dec;138(11-12):1259-1266. doi: 10.1007/s00439-019-02065-x. Epub 2019 Sep 25.
61	Pharmacological and proteomic analyses of neonatal polyI:C-treated adult mice.Neurosci Res. 2019 Oct;147:39-47. doi: 10.1016/j.neures.2018.10.007. Epub 2018 Oct 26.
62	Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders.Mol Neurobiol. 2018 Oct;55(10):7921-7940. doi: 10.1007/s12035-018-0911-5. Epub 2018 Feb 27.
63	A novel splice site mutation in AP1S2 gene for X-linked mental retardation in a Chinese pedigree and literature review.Brain Behav. 2019 Mar;9(3):e01221. doi: 10.1002/brb3.1221. Epub 2019 Feb 4.
64	Sublaminar organization of the human subplate: developmental changes in the distribution of neurons, glia, growing axons and extracellular matrix.J Anat. 2019 Sep;235(3):481-506. doi: 10.1111/joa.12920. Epub 2018 Dec 13.
65	GPCR-independent activation of G proteins promotes apical cell constriction in vivo.J Cell Biol. 2019 May 6;218(5):1743-1763. doi: 10.1083/jcb.201811174. Epub 2019 Apr 4.
66	The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype-phenotype correlations, and molecular basis.Genet Med. 2020 Feb;22(2):389-397. doi: 10.1038/s41436-019-0612-0. Epub 2019 Aug 7.
67	De novo variants in CNOT3 cause a variable neurodevelopmental disorder.Eur J Hum Genet. 2019 Nov;27(11):1677-1682. doi: 10.1038/s41431-019-0413-6. Epub 2019 Jun 14.
68	Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.Mol Autism. 2018 Aug 15;9:44. doi: 10.1186/s13229-018-0227-3. eCollection 2018.
69	Deficiency of aminopeptidase P1 causes behavioral hyperactivity, cognitive deficits, and hippocampal neurodegeneration.Genes Brain Behav. 2018 Feb;17(2):126-138. doi: 10.1111/gbb.12419. Epub 2017 Sep 15.
70	Cux2 expression regulated by Lhx2 in the upper layer neurons of the developing cortex.Biochem Biophys Res Commun. 2020 Jan 22;521(4):874-879. doi: 10.1016/j.bbrc.2019.11.004. Epub 2019 Nov 8.
71	Three human aminoacyl-tRNA synthetases have distinct sub-mitochondrial localizations that are unaffected by disease-associated mutations.J Biol Chem. 2018 Aug 31;293(35):13604-13615. doi: 10.1074/jbc.RA118.003400. Epub 2018 Jul 13.
72	Cognitive impairment and autistic-like behaviour in SAPAP4-deficient mice.Transl Psychiatry. 2019 Jan 16;9(1):7. doi: 10.1038/s41398-018-0327-z.
73	Rare copy number variations affecting the synaptic gene DMXL2 in neurodevelopmental disorders.J Neurodev Disord. 2019 Feb 7;11(1):3. doi: 10.1186/s11689-019-9263-3.
74	DOCK3-related neurodevelopmental syndrome: Biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia.Am J Med Genet A. 2018 Jan;176(1):241-245. doi: 10.1002/ajmg.a.38517. Epub 2017 Nov 12.
75	DPH1 syndrome: two novel variants and structural and functional analyses of seven missense variants identified in syndromic patients.Eur J Hum Genet. 2020 Jan;28(1):64-75. doi: 10.1038/s41431-019-0374-9. Epub 2019 Mar 15.
76	USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1.Nucleic Acids Res. 2018 Jan 25;46(2):823-839. doi: 10.1093/nar/gkx1226.
77	Novel EXOSC3 pathogenic variant results in a mild course of neurologic disease with cerebellum involvement.Eur J Med Genet. 2020 Feb;63(2):103649. doi: 10.1016/j.ejmg.2019.04.006. Epub 2019 Apr 12.
78	Possible involvement of a cell adhesion molecule, Migfilin, in brain development and pathogenesis of autism spectrum disorders.J Neurosci Res. 2018 May;96(5):789-802. doi: 10.1002/jnr.24194. Epub 2017 Nov 8.
79	Variantrecurrence in neurodevelopmental disorders: the use of publicly available genomic data identifies clinically relevant pathogenic missense variants.Genet Med. 2019 Nov;21(11):2504-2511. doi: 10.1038/s41436-019-0518-x. Epub 2019 Apr 30.
80	Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.BMC Med Genomics. 2018 May 25;11(1):50. doi: 10.1186/s12920-018-0362-x.
81	The epileptology of GNB5 encephalopathy.Epilepsia. 2019 Nov;60(11):e121-e127. doi: 10.1111/epi.16372. Epub 2019 Oct 20.
82	Disturbed neurotransmitter homeostasis in ether lipid deficiency.Hum Mol Genet. 2019 Jun 15;28(12):2046-2061. doi: 10.1093/hmg/ddz040.
83	Biallelic inactivating variants in the GTPBP2 gene cause a neurodevelopmental disorder with severe intellectual disability.Eur J Hum Genet. 2018 Apr;26(4):592-598. doi: 10.1038/s41431-018-0097-3. Epub 2018 Feb 15.
84	Deficiency of calcium/calmodulin-dependent serine protein kinase disrupts the excitatory-inhibitory balance of synapses by down-regulating GluN2B.Mol Psychiatry. 2019 Jul;24(7):1079-1092. doi: 10.1038/s41380-018-0338-4. Epub 2019 Jan 4.
85	Brain-specific deletion of histone variant H2A.z results in cortical neurogenesis defects and neurodevelopmental disorder.Nucleic Acids Res. 2018 Mar 16;46(5):2290-2307. doi: 10.1093/nar/gkx1295.
86	Association of IMMP2L deletions with autism spectrum disorder: A trio family study and meta-analysis.Am J Med Genet B Neuropsychiatr Genet. 2018 Jan;177(1):93-100. doi: 10.1002/ajmg.b.32608. Epub 2017 Nov 20.
87	Biallelic INTS1 Mutations Cause a Rare Neurodevelopmental Disorder in Two Chinese Siblings.J Mol Neurosci. 2020 Jan;70(1):1-8. doi: 10.1007/s12031-019-01393-x. Epub 2019 Aug 19.
88	Clinical significance of copy number variants involving KANK1 in patients with neurodevelopmental disorders.Eur J Med Genet. 2019 Jan;62(1):15-20. doi: 10.1016/j.ejmg.2018.04.012. Epub 2018 May 3.
89	CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.Mol Neurobiol. 2020 Feb;57(2):616-634. doi: 10.1007/s12035-019-01727-1. Epub 2019 Aug 11.
90	Efa6 protects axons and regulates their growth and branching by inhibiting microtubule polymerisation at the cortex.Elife. 2019 Nov 13;8:e50319. doi: 10.7554/eLife.50319.
91	Nail-patella syndrome with an emphasis on the risk of renal and ocular findings.Pediatr Dermatol. 2010 Jan-Feb;27(1):95-7. doi: 10.1111/j.1525-1470.2009.01051.x.
92	Biochemical and Morphological Characterization of a Neurodevelopmental Disorder-Related Mono-ADP-Ribosylhydrolase, MACRO Domain Containing 2.Dev Neurosci. 2018;40(3):278-287. doi: 10.1159/000492271. Epub 2018 Sep 18.
93	Emerging roles for MEF2 in brain development and mental disorders.Curr Opin Neurobiol. 2019 Dec;59:49-58. doi: 10.1016/j.conb.2019.04.008. Epub 2019 May 23.
94	Developmental diversification of cortical inhibitory interneurons.Nature. 2018 Mar 22;555(7697):457-462. doi: 10.1038/nature25999. Epub 2018 Mar 5.
95	de novo MEPCE nonsense variant associated with a neurodevelopmental disorder causes disintegration of 7SK snRNP and enhanced RNA polymerase II activation.Sci Rep. 2019 Aug 29;9(1):12516. doi: 10.1038/s41598-019-49032-0.
96	Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability.Am J Med Genet B Neuropsychiatr Genet. 2018 Jan;177(1):10-20. doi: 10.1002/ajmg.b.32574. Epub 2017 Oct 9.
97	Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment.J Neurol. 2020 Mar;267(3):770-782. doi: 10.1007/s00415-019-09640-2. Epub 2019 Nov 20.
98	Neurofascin (NFASC) gene mutation causes autosomal recessive ataxia with demyelinating neuropathy.Parkinsonism Relat Disord. 2019 Jun;63:66-72. doi: 10.1016/j.parkreldis.2019.02.045. Epub 2019 Mar 1.
99	Chromatin Decondensation by FOXP2 Promotes Human Neuron Maturation and Expression of Neurodevelopmental Disease Genes.Cell Rep. 2019 May 7;27(6):1699-1711.e9. doi: 10.1016/j.celrep.2019.04.044.
100	Novel mutations in NLGN3 causing autism spectrum disorder and cognitive impairment.Hum Mutat. 2019 Nov;40(11):2021-2032. doi: 10.1002/humu.23836. Epub 2019 Jul 29.
101	Molecular analysis of NPAS3 functional domains and variants.BMC Mol Biol. 2018 Dec 3;19(1):14. doi: 10.1186/s12867-018-0117-4.
102	Characterization of a Mouse Model of Brjeson-Forssman-Lehmann Syndrome.Cell Rep. 2018 Nov 6;25(6):1404-1414.e6. doi: 10.1016/j.celrep.2018.10.043.
103	Expression Analyses of POGZ, A Responsible Gene for Neurodevelopmental Disorders, during Mouse Brain Development.Dev Neurosci. 2019;41(1-2):139-148. doi: 10.1159/000502128. Epub 2019 Aug 20.
104	De novo apparent loss-of-function mutations in PRR12 in three patients with intellectual disability and iris abnormalities.Hum Genet. 2018 Mar;137(3):257-264. doi: 10.1007/s00439-018-1877-0. Epub 2018 Mar 19.
105	A homozygous canonical splice acceptor site mutation in PRUNE1 is responsible for a rare childhood neurodegenerative disease in Manitoba Cree families.Am J Med Genet A. 2019 Feb;179(2):206-218. doi: 10.1002/ajmg.a.60690. Epub 2018 Dec 17.
106	Postsynaptic density proteins and their involvement in neurodevelopmental disorders.J Biochem. 2018 Jun 1;163(6):447-455. doi: 10.1093/jb/mvy022.
107	Neurodevelopmental phenotype caused by a de novo PTPN4 single nucleotide variant disrupting protein localization in neuronal dendritic spines.Clin Genet. 2018 Dec;94(6):581-585. doi: 10.1111/cge.13450. Epub 2018 Oct 11.
108	De novo SCAMP5 mutation causes a neurodevelopmental disorder with autistic features and seizures.J Med Genet. 2020 Feb;57(2):138-144. doi: 10.1136/jmedgenet-2018-105927. Epub 2019 Aug 22.
109	The role of ISWI chromatin remodeling complexes in brain development and neurodevelopmental disorders.Mol Cell Neurosci. 2018 Mar;87:55-64. doi: 10.1016/j.mcn.2017.10.008. Epub 2017 Dec 15.
110	Putative contributions of the sex chromosome proteins SOX3 and SRY to neurodevelopmental disorders.Am J Med Genet B Neuropsychiatr Genet. 2019 Sep;180(6):390-414. doi: 10.1002/ajmg.b.32704. Epub 2018 Dec 9.
111	Exploring the association between SRPX2 variants and neurodevelopment: How causal is it?.Gene. 2019 Feb 15;685:50-54. doi: 10.1016/j.gene.2018.10.067. Epub 2018 Oct 25.
112	A novel nonsense and inactivating variant of ST3GAL3 in two infant siblings suffering severe epilepsy and expressing circulating CA19.9.Glycobiology. 2020 Jan 28;30(2):95-104. doi: 10.1093/glycob/cwz079.
113	TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish.Sci Rep. 2019 Jul 24;9(1):10730. doi: 10.1038/s41598-019-46632-8.
114	Purification and mutagenesis studies of TANC1 ankyrin repeats domain provide clues to understand mis-sense variants from diseases.Biochem Biophys Res Commun. 2019 Jun 25;514(2):358-364. doi: 10.1016/j.bbrc.2019.04.151. Epub 2019 Apr 27.
115	Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling.Mol Psychiatry. 2019 Sep;24(9):1329-1350. doi: 10.1038/s41380-018-0025-5. Epub 2018 Feb 21.
116	A case of early-onset epileptic encephalopathy with a homozygous TBC1D24 variant caused by uniparental isodisomy.Am J Med Genet A. 2019 Apr;179(4):645-649. doi: 10.1002/ajmg.a.61056. Epub 2019 Jan 24.
117	The Tousled-like kinases regulate genome and epigenome stability: implications in development and disease.Cell Mol Life Sci. 2019 Oct;76(19):3827-3841. doi: 10.1007/s00018-019-03208-z. Epub 2019 Jul 13.
118	Bi-allelic TMEM94 Truncating Variants Are Associated with Neurodevelopmental Delay, Congenital Heart Defects, and Distinct Facial Dysmorphism.Am J Hum Genet. 2018 Dec 6;103(6):948-967. doi: 10.1016/j.ajhg.2018.11.001.
119	Phenotype-to-genotype approach reveals head-circumference-associated genes in an autism spectrum disorder cohort.Clin Genet. 2020 Feb;97(2):338-346. doi: 10.1111/cge.13665. Epub 2019 Nov 14.
120	TOP3B: A Novel Candidate Gene in Juvenile Myoclonic Epilepsy?.Cytogenet Genome Res. 2018;154(1):1-5. doi: 10.1159/000486945. Epub 2018 Feb 28.
121	TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons.Mol Neurobiol. 2019 Apr;56(4):2640-2652. doi: 10.1007/s12035-018-1238-y. Epub 2018 Jul 26.
122	Laf4/Aff3, a gene involved in intellectual disability, is required for cellular migration in the mouse cerebral cortex.PLoS One. 2014 Aug 27;9(8):e105933. doi: 10.1371/journal.pone.0105933. eCollection 2014.
123	Genotype-phenotype correlations and expansion of the molecular spectrum of AP4M1-related hereditary spastic paraplegia.Orphanet J Rare Dis. 2017 Nov 2;12(1):172. doi: 10.1186/s13023-017-0721-2.
124	Gene dosage effect on gamma-secretase component Aph-1b in a rat model for neurodevelopmental disorders.Neuron. 2005 Feb 17;45(4):497-503. doi: 10.1016/j.neuron.2004.12.054.
125	Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures.Hum Mol Genet. 2013 May 15;22(10):2055-66. doi: 10.1093/hmg/ddt056. Epub 2013 Feb 7.
126	Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes.Hum Mol Genet. 2014 May 15;23(10):2752-68. doi: 10.1093/hmg/ddt669. Epub 2013 Dec 30.
127	Hereditary spastic paraplegia.Neurol Clin. 2002 Aug;20(3):711-26. doi: 10.1016/s0733-8619(02)00007-5.
128	Neurodevelopmental MACPFs: The vertebrate astrotactins and BRINPs.Semin Cell Dev Biol. 2017 Dec;72:171-181. doi: 10.1016/j.semcdb.2017.05.005. Epub 2017 May 12.
129	Ca(2+)-dependent activator protein for secretion 2 and autistic-like phenotypes.Neurosci Res. 2010 Jul;67(3):197-202. doi: 10.1016/j.neures.2010.03.006. Epub 2010 Mar 17.
130	Cc2d1a Loss of Function Disrupts Functional and Morphological Development in Forebrain Neurons Leading to Cognitive and Social Deficits.Cereb Cortex. 2017 Feb 1;27(2):1670-1685. doi: 10.1093/cercor/bhw009.
131	CDYL Deficiency Disrupts Neuronal Migration and Increases Susceptibility to Epilepsy.Cell Rep. 2017 Jan 10;18(2):380-390. doi: 10.1016/j.celrep.2016.12.043.
132	Long term follow-up in a patient with a de novo microdeletion of 14q11.2 involving CHD8.Am J Med Genet A. 2015 Apr;167A(4):837-41. doi: 10.1002/ajmg.a.36957. Epub 2015 Mar 3.
133	Contactin 4 as an autism susceptibility locus.Autism Res. 2011 Jun;4(3):189-99. doi: 10.1002/aur.184. Epub 2011 Feb 9.
134	Substrate specificity of human carboxypeptidase A6.J Biol Chem. 2010 Dec 3;285(49):38234-42. doi: 10.1074/jbc.M110.158626. Epub 2010 Sep 20.
135	Rare De Novo Missense Variants in RNA Helicase DDX6 Cause Intellectual Disability and Dysmorphic Features and Lead to P-Body Defects and RNA Dysregulation. Am J Hum Genet. 2019 Sep 5;105(3):509-525. doi: 10.1016/j.ajhg.2019.07.010. Epub 2019 Aug 15.
136	Novel loss-of-function variants in DIAPH1 associated with syndromic microcephaly, blindness, and early onset seizures.Am J Med Genet A. 2016 Feb;170A(2):435-440. doi: 10.1002/ajmg.a.37422. Epub 2015 Oct 13.
137	Collybistin binds and inhibits mTORC1 signaling: a potential novel mechanism contributing to intellectual disability and autism.Eur J Hum Genet. 2016 Jan;24(1):59-65. doi: 10.1038/ejhg.2015.69. Epub 2015 Apr 22.
138	Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4).Eur J Hum Genet. 2009 Sep;17(9):1171-81. doi: 10.1038/ejhg.2008.267. Epub 2009 Jan 28.
139	Intronic single nucleotide polymorphisms of engrailed homeobox 2 modulate the disease vulnerability of autism in a han chinese population.Neuropsychobiology. 2010;62(2):104-15. doi: 10.1159/000315441. Epub 2010 Jun 3.
140	EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.Brain. 2016 Mar;139(Pt 3):765-81. doi: 10.1093/brain/awv393.
141	Identification and characterization of FAM124B as a novel component of a CHD7 and CHD8 containing complex.PLoS One. 2012;7(12):e52640. doi: 10.1371/journal.pone.0052640. Epub 2012 Dec 21.
142	Frizzled 9 knock-out mice have abnormal B-cell development.Blood. 2005 Mar 15;105(6):2487-94. doi: 10.1182/blood-2004-06-2334. Epub 2004 Nov 30.
143	Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.Am J Hum Genet. 2014 May 1;94(5):677-94. doi: 10.1016/j.ajhg.2014.03.018. Epub 2014 Apr 24.
144	Indexing Effects of Copy Number Variation on Genes Involved in Developmental Delay.Sci Rep. 2016 Jul 1;6:28663. doi: 10.1038/srep28663.
145	Personalized genome sequencing coupled with iPSC technology identifies GTDC1 as a gene involved in neurodevelopmental disorders.Hum Mol Genet. 2017 Jan 15;26(2):367-382. doi: 10.1093/hmg/ddw393.
146	Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations.Neurobiol Dis. 2012 Mar;45(3):913-22. doi: 10.1016/j.nbd.2011.12.010. Epub 2011 Dec 11.
147	HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain.Hum Mol Genet. 2015 Jun 15;24(12):3335-47. doi: 10.1093/hmg/ddv083. Epub 2015 Mar 3.
148	The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.J Biol Chem. 2011 Dec 9;286(49):42051-42062. doi: 10.1074/jbc.M111.300541. Epub 2011 Oct 17.
149	Mutations of KIF5C cause a neurodevelopmental disorder of infantile-onset epilepsy, absent language, and distinctive malformations of cortical development.Am J Med Genet A. 2017 Dec;173(12):3127-3131. doi: 10.1002/ajmg.a.38496. Epub 2017 Oct 19.
150	Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder.Nat Neurosci. 2017 Sep;20(9):1217-1224. doi: 10.1038/nn.4598. Epub 2017 Jul 17.
151	LAMB1 polymorphism is associated with autism symptom severity in Korean autism spectrum disorder patients.Nord J Psychiatry. 2015;69(8):594-8. doi: 10.3109/08039488.2015.1022597. Epub 2015 Mar 16.
152	Implication of LRRC4C and DPP6 in neurodevelopmental disorders.Am J Med Genet A. 2017 Feb;173(2):395-406. doi: 10.1002/ajmg.a.38021. Epub 2016 Oct 19.
153	LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia.Mol Psychiatry. 2007 Dec;12(12):1129-39, 1057. doi: 10.1038/sj.mp.4002053. Epub 2007 Jul 31.
154	A null mutation in MICU2 causes abnormal mitochondrial calcium homeostasis and a severe neurodevelopmental disorder.Brain. 2017 Nov 1;140(11):2806-2813. doi: 10.1093/brain/awx237.
155	21q21 deletion involving NCAM2: report of 3 cases with neurodevelopmental disorders.Eur J Med Genet. 2015 Jan;58(1):44-6. doi: 10.1016/j.ejmg.2014.11.004. Epub 2014 Nov 20.
156	NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness.Cell Mol Life Sci. 2017 Apr;74(7):1191-1210. doi: 10.1007/s00018-016-2395-7. Epub 2016 Oct 14.
157	Norrie disease gene: characterization of deletions and possible function.Genomics. 1993 May;16(2):533-5. doi: 10.1006/geno.1993.1224.
158	A novel missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria and cleft palate.J Hum Genet. 2017 Sep;62(9):861-863. doi: 10.1038/jhg.2017.53. Epub 2017 May 18.
159	CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons.Nat Cell Biol. 2012 Sep;14(9):911-23. doi: 10.1038/ncb2566. Epub 2012 Aug 26.
160	A founder nonsense variant in NUDT2 causes a recessive neurodevelopmental disorder in Saudi Arab children.Clin Genet. 2018 Oct;94(3-4):393-395. doi: 10.1111/cge.13386. Epub 2018 Jul 30.
161	The emerging fragile X premutation phenotype: evidence from the domain of social cognition.Brain Cogn. 2005 Feb;57(1):53-60. doi: 10.1016/j.bandc.2004.08.020.
162	Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders.Epigenomics. 2015;7(3):503-19. doi: 10.2217/epi.15.1.
163	Alanine Expansions Associated with Congenital Central Hypoventilation Syndrome Impair PHOX2B Homeodomain-mediated Dimerization and Nuclear Import.J Biol Chem. 2016 Jun 17;291(25):13375-93. doi: 10.1074/jbc.M115.679027. Epub 2016 Apr 27.
164	Role of Class III phosphoinositide 3-kinase in the brain development: possible involvement in specific learning disorders.J Neurochem. 2016 Oct;139(2):245-255. doi: 10.1111/jnc.13832. Epub 2016 Sep 19.
165	Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.Hum Mol Genet. 2019 Nov 15;28(22):3842-3852. doi: 10.1093/hmg/ddz221.
166	Synaptic Dysfunction in Human Neurons With Autism-Associated Deletions in PTCHD1-AS.Biol Psychiatry. 2020 Jan 15;87(2):139-149. doi: 10.1016/j.biopsych.2019.07.014. Epub 2019 Jul 29.
167	Mutation in the X-linked RAB40AL gene (Martin-Probst syndrome) with mental retardation, sensorineural hearing loss, and anomalies of the craniofacies and genitourinary tract: a second case report.Eur J Pediatr. 2014 Jul;173(7):967-9. doi: 10.1007/s00431-014-2339-x. Epub 2014 May 27.
168	MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes.Eur J Hum Genet. 2015 Jun;23(6):781-9. doi: 10.1038/ejhg.2014.200. Epub 2014 Oct 1.
169	Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effects.Curr HIV Res. 2015;13(1):10-20. doi: 10.2174/1570162x13666150311163733.
170	Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome.Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6788-93. doi: 10.1073/pnas.1003108107. Epub 2010 Mar 29.
171	Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism.FASEB J. 2016 Nov;30(11):3669-3681. doi: 10.1096/fj.201600424. Epub 2016 Jul 29.
172	Chromosomal microarray analysis in clinical evaluation of neurodevelopmental disorders-reporting a novel deletion of SETDB1 and illustration of counseling challenge.Pediatr Res. 2016 Sep;80(3):371-81. doi: 10.1038/pr.2016.101. Epub 2016 Apr 27.
173	Autism multiplex family with 16p11.2p12.2 microduplication syndrome in monozygotic twins and distal 16p11.2 deletion in their brother.Eur J Hum Genet. 2012 May;20(5):540-6. doi: 10.1038/ejhg.2011.244. Epub 2012 Jan 11.
174	Essential role of the nuclear isoform of RBFOX1, a candidate gene for autism spectrum disorders, in the brain development.Sci Rep. 2016 Aug 2;6:30805. doi: 10.1038/srep30805.
175	Disruptive mutations in TANC2 define a neurodevelopmental syndrome associated with psychiatric disorders. Nat Commun. 2019 Oct 15;10(1):4679. doi: 10.1038/s41467-019-12435-8.
176	Mutations in ACTL6B, coding for a subunit of the neuron-specific chromatin remodeling complex nBAF, cause early onset severe developmental and epileptic encephalopathy with brain hypomyelination and cerebellar atrophy. Hum Genet. 2019 Feb;138(2):187-198. doi: 10.1007/s00439-019-01972-3. Epub 2019 Jan 17.
177	Microdeletion and microduplication of 1p36.11p35.3 involving AHDC1 contribute to neurodevelopmental disorder.Eur J Med Genet. 2020 Jan;63(1):103611. doi: 10.1016/j.ejmg.2019.01.001. Epub 2019 Jan 4.
178	Usp9X Controls Ankyrin-Repeat Domain Protein Homeostasis during Dendritic Spine Development.Neuron. 2020 Feb 5;105(3):506-521.e7. doi: 10.1016/j.neuron.2019.11.003. Epub 2019 Dec 5.
179	Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome. Nat Commun. 2019 Aug 6;10(1):3529. doi: 10.1038/s41467-019-11437-w.
180	Distinct functions of Trio GEF domains in axon outgrowth of cerebellar granule neurons.J Genet Genomics. 2019 Feb;46(2):87-96. doi: 10.1016/j.jgg.2019.02.003. Epub 2019 Feb 23.
181	Association Between Prematurity and Diagnosis of Neurodevelopment Disorder: A Case-Control Study.J Autism Dev Disord. 2020 Jan;50(1):145-152. doi: 10.1007/s10803-019-04235-2.
182	De novo loss-of-function variants of ASH1L are associated with an emergent neurodevelopmental disorder.Eur J Med Genet. 2019 Jan;62(1):55-60. doi: 10.1016/j.ejmg.2018.05.003. Epub 2018 May 22.
183	ASTN2 modulates synaptic strength by trafficking and degradation of surface proteins.Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9717-E9726. doi: 10.1073/pnas.1809382115. Epub 2018 Sep 21.
184	Recognizable facial features in patients with alternating hemiplegia of childhood.Am J Med Genet A. 2016 Oct;170(10):2698-705. doi: 10.1002/ajmg.a.37808. Epub 2016 Jun 17.
185	De novo exon 1 deletion of AUTS2 gene in a patient with autism spectrum disorder and developmental delay: a case report and a brief literature review.Am J Med Genet A. 2015 Jun;167(6):1381-5. doi: 10.1002/ajmg.a.37050. Epub 2015 Apr 6.
186	The BAF complex in development and disease.Epigenetics Chromatin. 2019 Mar 21;12(1):19. doi: 10.1186/s13072-019-0264-y.
187	A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.Mol Genet Genomic Med. 2019 Sep;7(9):e897. doi: 10.1002/mgg3.897. Epub 2019 Jul 25.
188	Association of 17q24.2-q24.3 deletions with recognizable phenotype and short telomeres.Am J Med Genet A. 2018 Jun;176(6):1438-1442. doi: 10.1002/ajmg.a.38711. Epub 2018 Apr 25.
189	De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism. Am J Hum Genet. 2018 Sep 6;103(3):448-455. doi: 10.1016/j.ajhg.2018.07.019. Epub 2018 Aug 16.
190	CHD2: One Gene, Many Roles.Neuron. 2018 Dec 5;100(5):1014-1016. doi: 10.1016/j.neuron.2018.11.036.
191	A current view on contactin-4, -5, and -6: Implications in neurodevelopmental disorders.Mol Cell Neurosci. 2017 Jun;81:72-83. doi: 10.1016/j.mcn.2016.12.004. Epub 2017 Jan 5.
192	Structural abnormalities in the primary somatosensory cortex and a normal behavioral profile in Contactin-5 deficient mice.Cell Adh Migr. 2018 Jan 2;12(1):5-18. doi: 10.1080/19336918.2017.1288788. Epub 2017 Mar 27.
193	CNTN6 copy number variations: Uncertain clinical significance in individuals with neurodevelopmental disorders.Eur J Med Genet. 2020 Jan;63(1):103636. doi: 10.1016/j.ejmg.2019.02.008. Epub 2019 Mar 2.
194	Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures.J Hum Genet. 2019 Apr;64(4):313-322. doi: 10.1038/s10038-018-0559-z. Epub 2019 Jan 17.
195	Three additional de novo CTCF mutations in Chinese patients help to define an emerging neurodevelopmental disorder.Am J Med Genet C Semin Med Genet. 2019 Jun;181(2):218-225. doi: 10.1002/ajmg.c.31698. Epub 2019 Mar 20.
196	Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures.Eur J Hum Genet. 2019 May;27(5):747-759. doi: 10.1038/s41431-018-0331-z. Epub 2019 Jan 21.
197	Impaired memory and marble burying activity in deformed epidermal autoregulatory factor 1 (Deaf1) conditional knockout mice.Behav Brain Res. 2020 Feb 17;380:112383. doi: 10.1016/j.bbr.2019.112383. Epub 2019 Nov 26.
198	Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.Biol Psychiatry. 2019 Feb 15;85(4):305-316. doi: 10.1016/j.biopsych.2018.05.009. Epub 2018 May 23.
199	Rare structural variants in the DOCK8 gene identified in a cohort of 439 patients with neurodevelopmental disorders.Sci Rep. 2018 Jun 21;8(1):9449. doi: 10.1038/s41598-018-27824-0.
200	Gonadal mosaicism of large terminal de novo duplication and deletion in siblings with variable intellectual disability phenotypes.Mol Genet Genomic Med. 2019 Oct;7(10):e00954. doi: 10.1002/mgg3.954. Epub 2019 Sep 1.
201	Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus.Front Genet. 2017 Mar 10;8:28. doi: 10.3389/fgene.2017.00028. eCollection 2017.
202	Mild epileptic phenotype associates with de novo eef1a2 mutation: Case report and review.Brain Dev. 2020 Jan;42(1):77-82. doi: 10.1016/j.braindev.2019.08.001. Epub 2019 Aug 30.
203	Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.Pharmacol Biochem Behav. 2019 Jun;181:93-100. doi: 10.1016/j.pbb.2019.05.002. Epub 2019 May 4.
204	The role of FOXG1 in the postnatal development and survival of mouse cochlear hair cells.Neuropharmacology. 2019 Jan;144:43-57. doi: 10.1016/j.neuropharm.2018.10.021. Epub 2018 Oct 15.
205	Cortical Foxp2 Supports Behavioral Flexibility and Developmental Dopamine D1 Receptor Expression.Cereb Cortex. 2020 Mar 14;30(3):1855-1870. doi: 10.1093/cercor/bhz209.
206	A novel human Cdh1 mutation impairs anaphase promoting complex/cyclosome activity resulting in microcephaly, psychomotor retardation, and epilepsy. J Neurochem. 2019 Oct;151(1):103-115. doi: 10.1111/jnc.14828. Epub 2019 Aug 22.
207	The NuRD complex and macrocephaly associated neurodevelopmental disorders.Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):548-556. doi: 10.1002/ajmg.c.31752. Epub 2019 Nov 18.
208	Novel GNB1 de novo mutation in a patient with neurodevelopmental disorder and cutaneous mastocytosis: Clinical report and literature review.Eur J Med Genet. 2018 Mar;61(3):157-160. doi: 10.1016/j.ejmg.2017.11.010. Epub 2017 Nov 23.
209	The FRA14B common fragile site maps to a region prone to somatic and germline rearrangements within the large GPHN gene.Genes Chromosomes Cancer. 2019 May;58(5):284-294. doi: 10.1002/gcc.22706. Epub 2018 Dec 20.
210	HACE1 deficiency causes an autosomal recessive neurodevelopmental syndrome. J Med Genet. 2015 Dec;52(12):797-803. doi: 10.1136/jmedgenet-2015-103344. Epub 2015 Sep 30.
211	De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia. J Med Genet. 2017 Feb;54(2):84-86. doi: 10.1136/jmedgenet-2016-103943. Epub 2016 Jul 7.
212	Proteomic investigations of human HERC2 mutants: Insights into the pathobiology of a neurodevelopmental disorder.Biochem Biophys Res Commun. 2019 Apr 30;512(2):421-427. doi: 10.1016/j.bbrc.2019.02.149. Epub 2019 Mar 19.
213	Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females. Am J Hum Genet. 2016 Sep 1;99(3):728-734. doi: 10.1016/j.ajhg.2016.06.028. Epub 2016 Aug 18.
214	Abnormal behaviours relevant to neurodevelopmental disorders in Kirrel3-knockout mice.Sci Rep. 2018 Jan 23;8(1):1408. doi: 10.1038/s41598-018-19844-7.
215	Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy. Am J Hum Genet. 2019 Jun 6;104(6):1210-1222. doi: 10.1016/j.ajhg.2019.03.021. Epub 2019 May 9.
216	MAB21L1 loss of function causes a syndromic neurodevelopmental disorder with distinctive cerebellar, ocular, craniofacial and genital features (COFG syndrome). J Med Genet. 2019 May;56(5):332-339. doi: 10.1136/jmedgenet-2018-105623. Epub 2018 Nov 28.
217	mTOR and autophagy pathways are dysregulated in murine and human models of Schaaf-Yang syndrome.Sci Rep. 2019 Nov 4;9(1):15935. doi: 10.1038/s41598-019-52287-2.
218	The E3 ubiquitin ligase APC/C(C)(dh1) degrades MCPH1 after MCPH1-TrCP2-Cdc25A-mediated mitotic entry to ensure neurogenesis.EMBO J. 2017 Dec 15;36(24):3666-3681. doi: 10.15252/embj.201694443. Epub 2017 Nov 17.
219	De novo mutations in MED13, a component of the Mediator complex, are associated with a novel neurodevelopmental disorder. Hum Genet. 2018 May;137(5):375-388. doi: 10.1007/s00439-018-1887-y. Epub 2018 May 8.
220	NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.J Neurosci. 2020 Jan 2;40(1):237-254. doi: 10.1523/JNEUROSCI.0222-19.2019. Epub 2019 Nov 8.
221	Downregulation of Npas4 in parvalbumin interneurons and cognitive deficits after neonatal NMDA receptor blockade: relevance for schizophrenia.Transl Psychiatry. 2019 Feb 21;9(1):99. doi: 10.1038/s41398-019-0436-3.
222	Thyroid hormone influences brain gene expression programs and behaviors in later generations by altering germ line epigenetic information.Mol Psychiatry. 2020 May;25(5):939-950. doi: 10.1038/s41380-018-0281-4. Epub 2018 Oct 24.
223	NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs.Nucleic Acids Res. 2019 Sep 19;47(16):8720-8733. doi: 10.1093/nar/gkz559.
224	Homozygous Missense Variants in NTNG2, Encoding a Presynaptic Netrin-G2 Adhesion Protein, Lead to a Distinct Neurodevelopmental Disorder. Am J Hum Genet. 2019 Nov 7;105(5):1048-1056. doi: 10.1016/j.ajhg.2019.09.025. Epub 2019 Oct 24.
225	De novo PHACTR1 mutations in West syndrome and their pathophysiological effects. Brain. 2018 Nov 1;141(11):3098-3114. doi: 10.1093/brain/awy246.
226	The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study. Eur J Hum Genet. 2019 Mar;27(3):408-421. doi: 10.1038/s41431-018-0299-8. Epub 2018 Dec 14.
227	De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder. Am J Hum Genet. 2019 Aug 1;105(2):403-412. doi: 10.1016/j.ajhg.2019.06.007. Epub 2019 Jul 11.
228	Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.
229	PSMD12 haploinsufficiency in a neurodevelopmental disorder with autistic features.Am J Med Genet B Neuropsychiatr Genet. 2018 Dec;177(8):736-745. doi: 10.1002/ajmg.b.32688. Epub 2018 Nov 13.
230	Bi-allelic mutations in TRAPPC2L result in a neurodevelopmental disorder and have an impact on RAB11 in fibroblasts. J Med Genet. 2018 Nov;55(11):753-764. doi: 10.1136/jmedgenet-2018-105441. Epub 2018 Aug 17.
231	RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior.Eur Neuropsychopharmacol. 2020 Jan;30:44-55. doi: 10.1016/j.euroneuro.2017.11.012. Epub 2017 Nov 23.
232	Reelin controls the positioning of brainstem serotonergic raphe neurons.PLoS One. 2018 Jul 12;13(7):e0200268. doi: 10.1371/journal.pone.0200268. eCollection 2018.
233	RPL10 mutation segregating in a family with X-linked syndromic Intellectual Disability.Am J Med Genet A. 2015 Aug;167A(8):1908-12. doi: 10.1002/ajmg.a.37094. Epub 2015 Apr 6.
234	Mutation update for the SATB2 gene.Hum Mutat. 2019 Aug;40(8):1013-1029. doi: 10.1002/humu.23771. Epub 2019 Jun 18.
235	De Novo and Inherited SETD1A Variants in Early-onset Epilepsy.Neurosci Bull. 2019 Dec;35(6):1045-1057. doi: 10.1007/s12264-019-00400-w. Epub 2019 Jun 13.
236	Genetic variations on SETD5 underlying autistic conditions.Dev Neurobiol. 2018 May;78(5):500-518. doi: 10.1002/dneu.22584. Epub 2018 Mar 5.
237	A direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders.J Neurodev Disord. 2018 Apr 17;10(1):15. doi: 10.1186/s11689-018-9233-1.
238	A Syndromic Neurodevelopmental Disorder Caused by Mutations in SMARCD1, a Core SWI/SNF Subunit Needed for Context-Dependent Neuronal Gene Regulation in Flies. Am J Hum Genet. 2019 Apr 4;104(4):596-610. doi: 10.1016/j.ajhg.2019.02.001. Epub 2019 Mar 14.
239	New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome.BMC Med Genomics. 2019 Jul 9;12(1):105. doi: 10.1186/s12920-019-0555-y.
240	Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay. Am J Hum Genet. 2019 Jan 3;104(1):164-178. doi: 10.1016/j.ajhg.2018.11.007. Epub 2018 Dec 20.
241	Novel Homozygous Deletion in STRADA Gene Associated With Polyhydramnios, Megalencephaly, and Epilepsy in 2 Siblings: Implications for Diagnosis and Treatment.J Child Neurol. 2018 Dec;33(14):925-929. doi: 10.1177/0883073818802724. Epub 2018 Oct 12.
242	STXBP1-associated neurodevelopmental disorder: a comparative study of behavioural characteristics.J Neurodev Disord. 2019 Aug 6;11(1):17. doi: 10.1186/s11689-019-9278-9.
243	SYNGAP1 mutations: Clinical, genetic, and pathophysiological features.Int J Dev Neurosci. 2019 Nov;78:65-76. doi: 10.1016/j.ijdevneu.2019.08.003. Epub 2019 Aug 24.
244	Functional characterization of TBR1 variants in neurodevelopmental disorder.Sci Rep. 2018 Sep 24;8(1):14279. doi: 10.1038/s41598-018-32053-6.
245	TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.Acta Neuropathol. 2019 Apr;137(4):657-673. doi: 10.1007/s00401-019-01982-5. Epub 2019 Mar 4.
246	TFE3-associated neurodevelopmental disorder: A distinct recognizable syndrome.Am J Med Genet A. 2020 Mar;182(3):584-590. doi: 10.1002/ajmg.a.61437. Epub 2019 Dec 12.
247	Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy. Brain. 2017 Mar 1;140(3):568-581. doi: 10.1093/brain/awx002.
248	Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.Mol Neurobiol. 2017 Aug;54(6):4257-4270. doi: 10.1007/s12035-016-9989-9. Epub 2016 Jun 23.
249	Trio Haploinsufficiency Causes Neurodevelopmental Disease-Associated Deficits.Cell Rep. 2019 Mar 5;26(10):2805-2817.e9. doi: 10.1016/j.celrep.2019.02.022.